Table 1:
Baseline characteristics of 77 cardiac sarcoidosis patients seen at Stanford University between 2009 and 2018
| Clinical Characteristic | Full Cohort (n =77) | Definite CS (n = 11) | Probable CS (n = 31) | Possible CS (n = 35) |
|---|---|---|---|---|
| Age at diagnosis (mean), years | 55 | 49 | 58 | 54 |
| Women | 30 (39) | 5 (45) | 14 (45) | 11 (31) |
| Race | ||||
| White | 51 (66) | 8 (73) | 18 (58) | 25 (71) |
| Black | 12 (16) | 2 (18) | 6 (19) | 4 (11) |
| Asian | 7 (9) | 0 | 4 (13) | 3 (9) |
| Hispanic | 7 (9) | 1 (9) | 3 (10) | 3 (9) |
| Smoking (ever) | 16 (21) | 2 (18) | 6 (19) | 8 (23) |
| Body mass index at diagnosis (mean) | 28 | 27 | 28 | 29 |
| Normal weight (< 25) | 18 (23) | 6 (55) | 5 (16) | 6 (17) |
| Overweight (≥ 25 and < 30) | 30 (39) | 2 (18) | 16 (52) | 13 (37) |
| Obese (≥ 30) | 29 (38) | 3 (27) | 10 (32) | 16 (46) |
| Initial clinical presentation | ||||
| Heart block | 36 (47) | 6 (55) | 16 (52) | 14 (40) |
| 1st degree | 10 | 1 | 6 | 3 |
| 2nd degree | 3 | 1 | 1 | 1 |
| 3rd degree | 23 | 4 | 9 | 10 |
| Tachyarrhythmia | 37 (48) | 6 (55) | 14 (45) | 17 (49) |
| Palpitations | 22 (29) | 3 (27) | 10 (32) | 9 (26) |
| Heart failure | 28 (36) | 5 (45) | 8 (26) | 15 (43) |
| Syncope | 16 (21) | 4 (36) | 4 (13) | 8 (23) |
| Follow-up (mean), years | 4.8 | 9.1 | 5.5 | 2.8 |
| Time to diagnosis from first symptom (mean), years | 3.3 | 2.9 | 2.7 | 3.9 |
*
Data are number (%) except for age, body mass index, follow-up, and time to diagnosis, which are mean (SD). CS = cardiac sarcoidosis.